Titan Pharmaceuticals, Inc. (TTNP)
Oct 2, 2025 - TTNP was delisted (reason: merged into BTTC).
4.610
-0.180 (-3.76%)
Inactive · Last trade price on Oct 1, 2025
Titan Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
6.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 184.00K | -373.00K | -66.97% |
| Dec 31, 2022 | 557.00K | -969.00K | -63.50% |
| Dec 31, 2021 | 1.53M | -3.31M | -68.46% |
| Dec 31, 2020 | 4.84M | 2.23M | 85.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTTNP News
- 2 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 4 months ago - Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 5 months ago - Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. - GlobeNewsWire
- 6 months ago - Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire